Ticker
RIGLCompany Name
RIGEL PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -0.58% | $ 434.8M | $ 2.52M |
3/31/2025 | -0.72% | $ 326.35M | $ 2.36M |
12/31/2024 | -0.5% | $ 394.41M | $ 1.96M |
9/30/2024 | -0.36% | $ 271.98M | $ 985K |
6/30/2024 | -0.51% | $ 164.16M | $ 836K |
3/31/2024 | -0.54% | $ 208.73M | $ 1.14M |
12/31/2023 | -0.4% | $ 259.56M | $ 1.05M |
9/30/2023 | -0.76% | $ 151.79M | $ 1.15M |
6/30/2023 | -0.49% | $ 231.9M | $ 1.14M |
3/31/2023 | -0.6% | $ 197.98M | $ 1.19M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for RIGEL PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 2.62M ]) / Market Cap [ $ 463.01M ]
(=) Buyback Yield [ -0.57% ]
Minimum
Sep 30, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.7% |